Form 8-K - Current report:
SEC Accession No. 0001213900-19-016813
Filing Date
2019-08-27
Accepted
2019-08-27 17:00:27
Documents
4
Period of Report
2019-08-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k082719_inmunebio.htm 8-K 17232
2 INMUNE BIO INVESTOR FACT SHEET f8k082719ex99-1_inmunebio.htm EX-99.1 9701
3 GRAPHIC ex99-1_001.jpg GRAPHIC 449938
4 GRAPHIC ex99-1_002.jpg GRAPHIC 419627
  Complete submission text file 0001213900-19-016813.txt   1214517
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 191058185
SIC: 2836 Biological Products, (No Diagnostic Substances)